#1 Clinical Trials Search in Europe
logo
Verified
High Ratings
70+ Specializations
200+ Therapies
Research Phase I/II/III

About Specializations

Samodzielny Publiczny Szpital Kliniczny Nr 4 W Lublinie in Lublin, Poland specializes in artificial kidney clinical trials.

Medical Center localisation

Ul. Dr. Kazimierza Jaczewskiego 8
20-090 Lublin, Poland

Want to learn more about this study or check if you can participate? Contact us.

Ongoing studies

  • Title: Evaluation of optimal timing for heparin anticoagulation in patients undergoing transseptal heart procedures (TEER or left atrial appendage closure)

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Poland

  • Study of acetylsalicylic acid and clopidogrel treatment after left atrial appendage closure in patients with atrial fibrillation and chronic kidney disease

    Not yet recruiting

    3 1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Poland

  • Study Comparing Volrustomig with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Czechia France Germany Hungary +5

  • Study on BIIB080 for Patients Aged 50-80 with Mild Cognitive Impairment or Mild Alzheimer’s Disease Dementia

    Not yet recruiting

    2 1 1
    Investigated drugs:
    Belgium Czechia Denmark Finland France Germany +5

  • Study on the Effectiveness and Safety of PLS240 for Treating Secondary Hyperparathyroidism in Patients with End-Stage Kidney Disease on Hemodialysis

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Poland Portugal Spain

  • Study of Datopotamab Deruxtecan and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with Low PD-L1 Levels

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Czechia France Germany Greece +7

  • Study on the Effectiveness and Safety of Ianalumab for Patients with Active Sjögren’s Syndrome

    Not recruiting

    3 1 1
    Investigated drugs:
    Austria Belgium Czechia France Germany Lithuania +3

  • A study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.

    Not recruiting

    3 1
    Investigated diseases:
    Austria Belgium Czechia Denmark France Germany +8

  • Study of Tarlatamab for Patients with Limited-Stage Small-Cell Lung Cancer After Chemoradiotherapy

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Bulgaria France Germany Greece +6

  • Study on the Effectiveness and Safety of Brensocatib for Patients with Chronic Rhinosinusitis Without Nasal Polyps

    Not recruiting

    2 1 1
    Investigated drugs:
    Belgium Bulgaria Czechia Denmark France Germany +5